Watch for Adverse Events With TMP-SMX in Lupus
(MedPage Today) -- Patients with systemic lupus erythematosus (SLE) who were given trimethoprim-sulfamethoxazole as prophylaxis for Pneumocystis pneumonia faced extra risk for adverse drug reactions relative to other patients considered vulnerable...
Read more »